AMD
Research Uncovers Differences in MNV Response to Anti-VEGF Therapy
Study finds type 2 macular neovascularization decreases more significantly in size and volume over one year of treatment.
10/03/2024
Beware Hypertransmission Defects of Any Size in Intermediate AMD
Eyes with high numbers of these findings appeared to be at a greater risk for progression.
09/19/2024
Geographic Atrophy: Looking Beyond VA
A discussion on the many other markers of visual function and quality in these patients, as well as the options available to help them see better.
09/15/2024
Study Observes Retinal Changes on OCT that Signal Progression in Early AMD
Identifying these subtle alterations in cell layers could allow for prompt diagnosis and treatment.
09/11/2024
Autoimmune Skin Condition Linked to AMD
Diabetic patients with psoriasis should be monitored for macular changes, study suggests.
09/05/2024
Raster Scans More Successful at Finding Fellow-eye Neovascularization
OCT crosshair scans missed the diagnosis in 16% of cases when used alone and was more common in those with type 3 MNV.
08/27/2024
Check the Hyporeflective Band to Differentiate AMD from Aging
Within the RPE basal lamina/Bruch’s membrane complex, the ETDRS inner ring was the most sensitive location to detect structural changes in both scenarios with prototype hi-res SD-OCT.
08/19/2024
Some Blood Thinners May Increase Conversion to Wet AMD
Warfarin-treated patients had more ocular complications than those on direct oral anticoagulants.
08/08/2024
Retinal Sensitivity Varies Across Macula in Early, Intermediate AMD
A recent study correlated microperimetry and contrast sensitivity findings with disease stage, suggesting potential new ways to tracking progression.
07/26/2024
Study Highlights Prognostic Value of Choriocapillaris Alterations in AMD Progression
This offers a potential biomarker for risk stratification and monitoring that could lead to more targeted clinical interventions, researchers say.
07/23/2024
Upcoming Events
November 6, 2024
Showcasing Inflammation and IOP Control
Location: Prime 47
Presenters: Marc Bloomenstein, OD, and Nora Lee Cothran, OD
Time: 7:00pm CT
Sponsored by Bausch + Lomb
November 13, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Harry Boparai, OD, and Doug Katsev, MD
Webinar: 7:00pm PT
Sponsored by Bausch + Lomb
November 13, 2024
The 3 I's of Geographic Atrophy: Imaging, Identification, and Intervention
Location: Virtual
Presenters: Jordana Fein, MD, and Julie Rodman, OD, MS,
Webinar: 9:30pm ET
Sponsored by Apellis
